Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Boggild

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2013
Role of intravenous immunoglobulin in the treatment of acute relapses of neuromyelitis optica: experience in 10 patientsLiene Elsone, Jay Panicker, Kerry Mutch, et al.
Multiple Sclerosis and Related Disorders|January 30, 2022
Low vitamin D levels do not predict risk of autoimmune disease following alemtuzumab treatment for multiple sclerosisSimon Arnett, Sofia Jimenez Sanchez, Jennifer Downing, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 2012
Neuropathic pruritus (itch) in neuromyelitis opticaLiene Elsone, Tristan Townsend, Kerry Mutch, et al.
BMJ Neurology Open|June 24, 2024
Planned dose reduction of ocrelizumab in relapsing-remitting multiple sclerosis: a single-centre observational studyTrung Dang Quoc Tran, Leanne Hall, Clare Heal, et al.
Clinical Neuropharmacology|June 11, 2009
Treatment of acquired periodic alternating nystagmus with memantine: a case reportAnil Kumar, Shery Thomas, Rebecca McLean, et al.
BMJ (Clinical Research Ed.)|December 4, 2009
Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparatorMike Boggild, Jackie Palace, Pelham Barton, et al.
Journal of Neurology|May 22, 2013
The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United KingdomAnu Jacob, Jay Panicker, Daniel Lythgoe, et al.
Neurology|August 24, 2012
Does natalizumab therapy worsen neuromyelitis optica?Anu Jacob, Michael Hutchinson, Liene Elsone, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 11, 2011
Genetic variations within the OPA1 gene are not associated with neuromyelitis opticaKamil S Sitarz, Patrick Yu-Wai-Man, Gavin Hudson, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 25, 2011
Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5DMatthijs M Versteegh, Annemieke Leunis, Jolanda J Luime, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2013
Role of intravenous immunoglobulin in the treatment of acute relapses of neuromyelitis optica: experience in 10 patientsLiene Elsone, Jay Panicker, Kerry Mutch, et al.
Multiple Sclerosis and Related Disorders|January 30, 2022
Low vitamin D levels do not predict risk of autoimmune disease following alemtuzumab treatment for multiple sclerosisSimon Arnett, Sofia Jimenez Sanchez, Jennifer Downing, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 2012
Neuropathic pruritus (itch) in neuromyelitis opticaLiene Elsone, Tristan Townsend, Kerry Mutch, et al.
BMJ Neurology Open|June 24, 2024
Planned dose reduction of ocrelizumab in relapsing-remitting multiple sclerosis: a single-centre observational studyTrung Dang Quoc Tran, Leanne Hall, Clare Heal, et al.
Clinical Neuropharmacology|June 11, 2009
Treatment of acquired periodic alternating nystagmus with memantine: a case reportAnil Kumar, Shery Thomas, Rebecca McLean, et al.
BMJ (Clinical Research Ed.)|December 4, 2009
Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparatorMike Boggild, Jackie Palace, Pelham Barton, et al.
Journal of Neurology|May 22, 2013
The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United KingdomAnu Jacob, Jay Panicker, Daniel Lythgoe, et al.
Neurology|August 24, 2012
Does natalizumab therapy worsen neuromyelitis optica?Anu Jacob, Michael Hutchinson, Liene Elsone, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 11, 2011
Genetic variations within the OPA1 gene are not associated with neuromyelitis opticaKamil S Sitarz, Patrick Yu-Wai-Man, Gavin Hudson, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 25, 2011
Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5DMatthijs M Versteegh, Annemieke Leunis, Jolanda J Luime, et al.
Pageof 6